Immediate Impact
26 from Science/Nature 69 standout
Citing Papers
Targeting HER2-positive breast cancer: advances and future directions
2022 Standout
Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
2021 Standout
Works of Jay Overholser being referenced
Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors
2019
Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
2000
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jay Overholser | 433 | 351 | 136 | 178 | 16 | 750 | |
| Azadeh Arabzadeh | 527 | 345 | 160 | 255 | 20 | 977 | |
| S. Virudachalam | 644 | 354 | 201 | 143 | 17 | 986 | |
| Hillary J. Millar | 481 | 348 | 81 | 242 | 14 | 756 | |
| D. Fan | 401 | 358 | 128 | 97 | 23 | 796 | |
| Luigi Manenti | 328 | 454 | 77 | 278 | 18 | 859 | |
| Karen Morrison | 295 | 228 | 78 | 174 | 23 | 811 | |
| L Deneux | 377 | 340 | 130 | 313 | 17 | 826 | |
| Ángel Santiago | 689 | 325 | 78 | 137 | 16 | 895 | |
| Doreen LePage | 442 | 288 | 131 | 162 | 19 | 871 | |
| Jason R. Neil | 560 | 364 | 111 | 75 | 14 | 922 |
All Works
Loading papers...